TECH vs. VTRS: Bio-Techne vs. Viatris Stock Comparison

Company Profile

Bio-Techne (TECH) and Viatris (VTRS) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but TECH is classified in Life Sciences Tools & Services while VTRS is classified in Pharmaceuticals.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Viatris (VTRS) reports a negative ROE of -4.21%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Bio-Techne (TECH) reports 8.33%, ranking against industry peers normally.

Viatris (VTRS) reports a negative net margin of -4.13%, usually indicating a net loss over the period. Meanwhile Bio-Techne (TECH) reports 14.00%, ranking against industry peers normally.

Both Bio-Techne (TECH) at 12.21% and Viatris (VTRS) at 13.85% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

Profitability Metrics

Growth

Bio-Techne (TECH) at -0.38% is around its peer norm for revenue growth, while Viatris (VTRS) at -2.98% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Only one side can be read here: Bio-Techne (TECH) reports EPS growth of 152.17%, ranked against its industry; Viatris (VTRS) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Both Bio-Techne (TECH) at 2.28 and Viatris (VTRS) at 1.55 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Bio-Techne (TECH) at 0.13 carries an industry-typical debt-to-equity mix, while Viatris (VTRS) at 0.99 uses more debt funding than most peers.

Financial Strength Metrics

Dividends

Both Bio-Techne (TECH) at 0.44% and Viatris (VTRS) at 2.53% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.

Viatris (VTRS) reports payout ratio above 100% at 960.00%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Bio-Techne (TECH) reports 27.59%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Bio-Techne (TECH) trades at 62.74 times trailing earnings, ranked against its peers, while Viatris (VTRS) has no P/E ratio this period.

Viatris (VTRS) at 1.55 sits in the cheaper P/S ratio quartile while Bio-Techne (TECH) at 9.31 prices around its industry’s middle — VTRS costs less per dollar of sales, though read it alongside growth and margins.

Viatris (VTRS) at 1.67 sits in the lower P/B ratio quartile against book while Bio-Techne (TECH) at 5.28 is valued near its industry’s middle — VTRS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics